148 related articles for article (PubMed ID: 15487882)
1. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis.
Nguyen TV; Dikun M
Am J Health Syst Pharm; 2004 Sep; 61(18):1922-4. PubMed ID: 15487882
[No Abstract] [Full Text] [Related]
2. Alteplase use for clotted catheters.
Macon EJ
Semin Dial; 2002; 15(1):72. PubMed ID: 11874599
[No Abstract] [Full Text] [Related]
3. Managing catheter dysfunction for better patient outcomes: a team approach.
Dinwiddie LC
Nephrol Nurs J; 2004; 31(6):653-60, 671; quiz 661-2. PubMed ID: 15686329
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
Little MA; Walshe JJ
Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, safety, and cost of thrombolytic agents for the management of dysfunctional hemodialysis catheters: a systematic review.
Hilleman D; Campbell J
Pharmacotherapy; 2011 Oct; 31(10):1031-40. PubMed ID: 21950645
[TBL] [Abstract][Full Text] [Related]
6. The use of tissue plasminogen activator infusion to re-establish function of tunneled hemodialysis catheters.
Dowling K; Sansivero G; Stainken B; Siskin G; Dolen E; Ahn J; Mitchell N
Nephrol Nurs J; 2004; 31(2):199-200. PubMed ID: 15114800
[TBL] [Abstract][Full Text] [Related]
7. Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Vercaigne LM; Zacharias J; Bernstein KN
Clin Nephrol; 2012 Oct; 78(4):287-96. PubMed ID: 22541682
[TBL] [Abstract][Full Text] [Related]
8. Using alteplase to clear occlusions.
Moureau N
Nursing; 2002 Jan; 32(1):73. PubMed ID: 12926500
[No Abstract] [Full Text] [Related]
9. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
10. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
11. Alteplase for the treatment of catheter occlusion in pediatric patients.
Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
[TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Ponec D; Irwin D; Haire WD; Hill PA; Li X; McCluskey ER;
J Vasc Interv Radiol; 2001 Aug; 12(8):951-5. PubMed ID: 11487675
[TBL] [Abstract][Full Text] [Related]
13. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters].
Ibrik O; Samon R; Roca R; Viladoms J; Mora J
Nefrologia; 2006; 26(6):719-25. PubMed ID: 17227250
[TBL] [Abstract][Full Text] [Related]
14. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
15. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
16. Successful Rescue Utilization of Intraoperative Tissue Plasminogen Activator in the Setting of Massive Thrombosis of Avalon Catheter and Patient in Extremis with Refractory Hypoxemia.
Martin AK; Allen WL; Fritz AV; Diaz-Gomez JL
J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2278-2281. PubMed ID: 29395819
[No Abstract] [Full Text] [Related]
17. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters.
Daeihagh P; Jordan J; Chen J; Rocco M
Am J Kidney Dis; 2000 Jul; 36(1):75-9. PubMed ID: 10873875
[TBL] [Abstract][Full Text] [Related]
18. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
Eyrich H; Walton T; Macon EJ; Howe A
Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
[TBL] [Abstract][Full Text] [Related]
19. Dialysis catheters and recombinant tissue plasminogen activator.
Allon M
N Engl J Med; 2011 May; 364(18):1779; author reply 1779-80. PubMed ID: 21542758
[No Abstract] [Full Text] [Related]
20. Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients.
Shen V; Li X; Murdock M; Resnansky L; McCluskey ER; Semba CP;
J Pediatr Hematol Oncol; 2003 Jan; 25(1):38-45. PubMed ID: 12544772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]